Skip to main content
. 2022 Jun 22;14(13):3065. doi: 10.3390/cancers14133065

Table 4.

MBSS Part A and Part B scores: classification performance and sub-group analysis.

Milan Biometric Surgical Score for Intracranial Meningiomas (MBSS-Men Score; Part A)
ITEM MEASURE SCORE VALUE
ASA Score 1–2 0
>2 3
Frailty Index <0.10 0 Multivariate regression analysis Odd Ratio (OD) Standard Error (S.E.) p Value 95% C.I.
0.10–0.20 2
>0.20 3 Post-operative prognostic Score MBSS (Part A) 2.611 0.293 0.001 1.469–4.640
Skull base location Yes 1 Constant 0 3.056 0
No 0
Infratentorial location Yes 3 AUR-ROC analysis Area (AUC) Std. Error (S.E.) p Value 95% C.I.
No 0
Diameter > 2.5 cm >25 mm 3 Overall population 0.956 0.034 0 0.890–1.022
<25 mm 0 Age 18–65 years 0.878 0.042 0 0.794–0.961
Tumor-Brain cleft on T2WI Absent 2 Age > 65 years 0.981 0.017 0 0.948–1.013
Present 0 Age > 70 years 0.973 0.024 0 0.926–1.020
RANGE 0–15 Age > 80 years 0.911 0.074 0 0.765–1.057
Milan Biometric Surgical Score for intracranial meningiomas (MBSS-Men Score; Part B)
Frailty Index <0.10 0
0.10–0.20 1
>0.20 3
Infratentorial location Yes 2
No 0 Multivariate regression analysis Odd Ratio (OD) Standard Error (S.E.) p Value 95% C.I.
Diameter > 2.5 cm >25 mm 1
<25 mm 0 Follow-up prognostic Score MBSS (Part B) 2.961 0.203 0 1.988–4.411
Severe peritumoral edema Yes 1 Constant 0.004 0.876 0
No 0
Sinus Invasion Yes 1 AUR-ROC analysis Area (AUC) Std. Error (S.E.) p Value 95% C.I.
No 0
DWI hyperintensity Present 1 Overall population 0.877 0.033 0 0.811–0.942
Absent 0 Age 18–65 years 0.901 0.04 0 0.823–0.978
Tumor-Brain cleft in T2WI Absent 1 Age > 65 years 0.854 0.054 0 0.749–0.959
Present 0 Age > 70 years 0.85 0.055 0 0.741–0.959
RANGE 0–10 Age > 80 years 0.861 0.088 0 0.689–1.033

(Left) The parameters independently associated with the outcomes investigated were selected and filled into a newly designed prognostic score. The Milan Biometric Surgical Score (MBSS) was split in two subparts: Part A comprehended all of the significant predictors of early post-operative functional outcome, while Part B comprehended those predictors affecting long-term functional outcome and quality of life. A chart for MBSS was designed and each parameter was given a value according to its odds ratio on a multivariable regression analysis. MBSS-Part A had a range from 0 to 15. MBSS-Part B had a range from 0 to 10. (Right) The current table reports the classification analysis of MBSS Part A and Part B in predicting early post-operative functional deterioration and long-term unfavourable outcome at follow-up, respectively. Each sub-score was tested first on the overall population and then on the age-specific subgroups.